Refine your search
Collections
Co-Authors
Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Periasamy, Perianayaki
- A Big Picture on Antimicrobial Strategies then and now
Abstract Views :416 |
PDF Views:0
Authors
Gurudharshini Natarajan
1,
Madhumitha Muthusamy
1,
Muthusaravanan Sivaramakrishnan
1,
Perianayaki Periasamy
1,
A. Poornimmashree
1,
Kumaravel Kandaswamy
1
Affiliations
1 Department of Biotechnology, Kumaraguru College of Technology, Coimbatore 641049, Tamil Nadu, IN
1 Department of Biotechnology, Kumaraguru College of Technology, Coimbatore 641049, Tamil Nadu, IN
Source
Research Journal of Engineering and Technology, Vol 8, No 4 (2017), Pagination: 361-364Abstract
Antimicrobial resistance (AMR) pose a serious threat to the physicians as bacterial strains evolve to counteract the effects of medication. Staphylococcus aureus is one such bacterial strain that was well known for its resistance to methicillin - a narrow-spectrum β-lactam antibiotic of the penicillin class. Although Methicillin-resistant S. aureus (MRSA) is not always pathogenic but historically associated with Hospital Acquired Infections (HAI), respiratory infections such as sinusitis, and food poisoning. In the recent years, bacterial strains such as Pseudomonas aeruginosa, Escherichia coli, Enterococcus faecalis, Streptococcus pyogenes have also been identified and well-studied for their ability to counteract antimicrobials. On this note, this article provides a comprehensive understanding on the antimicrobial strategies adopted globally to overcome the threat of drug resistant bacterial strains.Keywords
Bacterial Strains, Antimicrobials, Antimicrobial Strategies, Drug Resistance, Antibiotics.
References
- M.P. Jevons, A. Coe and M. Parker. Methicillin resistance in staphylococci, The Lancet, 281 (1963) 904-907.
- H. Boman. Antibacterial peptides: basic facts and emerging concepts, Journal of internal medicine, 254 (2003) 197-215.
- M. Nilsson, S. Wasylik, M. Mörgelin, A.I. Olin, J. Meijers, R.H. Derksen, P.G. De Gischolar_main and H. Herwald. The antibacterial activity of peptides derived from human beta‐2 glycoprotein I is inhibited by protein H and M1 protein from Streptococcus pyogenes, Molecular microbiology, 67 (2008) 482-492.
- S.M. Moskowitz, R.K. Ernst and S.I. Miller. PmrAB, a two-component regulatory system of Pseudomonas aeruginosa that modulates resistance to cationic antimicrobial peptides and addition of aminoarabinose to lipid A, Journal of bacteriology, 186 (2004) 575-579.
- K. De Smet and R. Contreras. Human antimicrobial peptides: defensins, cathelicidins and histatins, Biotechnology letters, 27 (2005) 1337-1347.
- M. Zasloff. Antimicrobial peptides of multicellular organisms, nature, 415 (2002) 389-395.
- 7.K. Kandaswamy, T.H. Liew, C.Y. Wang, E. Huston-Warren, U. Meyer-Hoffert, K. Hultenby, J.M. Schroder, M.G. Caparon, S. Normark, B. Henriques-Normark, S.J. Hultgren and K.A. Kline, Focal targeting by human beta-defensin 2 disrupts localized virulence factor assembly sites in Enterococcus faecalis, Proceedings of the National Academy of Sciences of the United States of America, 110 (2013) 20230-20235.
- P. Nyberg, M. Rasmussen and L. Björck. α2-Macroglobulin-proteinase complexes protect Streptococcus pyogenes from killing by the antimicrobial peptide LL-37, Journal of Biological Chemistry, 279 (2004) 52820-52823.
- I.-M. Frick, P. Åkesson, M. Rasmussen, A. Schmidtchen and L. Björck. SIC, A Secreted Protein of Streptococcus pyogenesThat Inactivates Antibacterial Peptides, Journal of Biological Chemistry, 278 (2003) 16561-16566.
- A. Patrzykat, C.L. Friedrich, L. Zhang, V. Mendoza and R.E. Hancock. Sublethal concentrations of pleurocidin-derived antimicrobial peptides inhibit macromolecular synthesis in Escherichia coli, Antimicrobial agents and chemotherapy, 46 (2002) 605-614.
- W. Liu, S.L. Dong, F. Xu, X.Q. Wang, T.R. Withers, D.Y. Hongwei and X. Wang. Effect of intracellular expression of antimicrobial peptide LL-37 on growth of Escherichia coli strain TOP10 under aerobic and anaerobic conditions, Antimicrobial agents and chemotherapy, 57 (2013) 4707-4716.
- D. Bolintineanu, E. Hazrati, H.T. Davis, R.I. Lehrer and Y.N. Kaznessis. Antimicrobial mechanism of pore-forming protegrin peptides: 100 pores to kill E. coli, Peptides, 31 (2010) 1-8.
- H.G. Boman, B. Agerberth and A. Boman. Mechanisms of action on Escherichia coli of cecropin P1 and PR-39, two antibacterial peptides from pig intestine, Infection and immunity, 61 (1993) 2978-2984.
- I. Sidén and H.G. Boman. Escherichia coli mutants with an altered sensitivity to cecropin D, Journal of bacteriology, 154 (1983) 170-176.
- E.L. Macfarlane, A. Kwasnicka and R.E. Hancock. Role of Pseudomonas aeruginosa PhoP-PhoQ in resistance to antimicrobial cationic peptides and aminoglycosides, Microbiology, 146 (2000) 2543-2554.
- S.J. Pamp, M. Gjermansen, H.K. Johansen and T. Tolker‐Nielsen. Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB‐oprM genes, Molecular microbiology, 68 (2008) 223-240.
- L. Li, Y. Shi, M.J. Cheserek, G. Su and G. Le. Antibacterial activity and dual mechanisms of peptide analog derived from cell-penetrating peptide against Salmonella typhimurium and Streptococcus pyogenes, Applied microbiology and biotechnology, 97 (2013) 1711-1723.